Winnie W. Nelson

4.0k total citations · 1 hit paper
113 papers, 2.8k citations indexed

About

Winnie W. Nelson is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Winnie W. Nelson has authored 113 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 18 papers in Internal Medicine. Recurrent topics in Winnie W. Nelson's work include Atrial Fibrillation Management and Outcomes (50 papers), Venous Thromboembolism Diagnosis and Management (18 papers) and Health Systems, Economic Evaluations, Quality of Life (17 papers). Winnie W. Nelson is often cited by papers focused on Atrial Fibrillation Management and Outcomes (50 papers), Venous Thromboembolism Diagnosis and Management (18 papers) and Health Systems, Economic Evaluations, Quality of Life (17 papers). Winnie W. Nelson collaborates with scholars based in United States, Canada and Belgium. Winnie W. Nelson's co-authors include Jeff Schein, Patrick Lefèbvre, François Laliberté, J. Bradford Rice, Alan G. White, Jeffrey Schein, George J. Wan, Lauren M. Scarpati, Craig I Coleman and Concetta Crivera and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Winnie W. Nelson

112 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review

2017 335 citations J. Bradford Rice, Alan G. White et al. Clinical Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Winnie W. Nelson United States	29	1.3k	640	452	349	303	113	2.8k
Kenneth M. Shermock United States	27	435 0.3×	504 0.8×	389 0.9×	267 0.8×	217 0.7×	89	2.0k
Chiara Melloni United States	27	1.2k 0.9×	285 0.4×	419 0.9×	190 0.5×	158 0.5×	102	2.6k
Rikke Sørensen Denmark	27	2.3k 1.8×	619 1.0×	650 1.4×	284 0.8×	141 0.5×	91	3.9k
Arlene M. Gallagher United Kingdom	19	851 0.6×	265 0.4×	410 0.9×	727 2.1×	306 1.0×	40	3.4k
Stephen S. Johnston United States	28	989 0.8×	213 0.3×	748 1.7×	329 0.9×	261 0.9×	135	3.2k
Ellen Murray United Kingdom	21	2.2k 1.7×	699 1.1×	261 0.6×	584 1.7×	272 0.9×	66	2.9k
Steven M. Bradley United States	37	2.4k 1.8×	210 0.3×	1.4k 3.1×	582 1.7×	266 0.9×	178	4.7k
Jelle Stoffers Netherlands	31	1.2k 0.9×	710 1.1×	1.9k 4.2×	450 1.3×	352 1.2×	95	3.8k
Charles K. Francis United States	19	2.3k 1.7×	369 0.6×	1.3k 3.0×	456 1.3×	90 0.3×	58	3.8k
Joseph Menzin United States	35	602 0.5×	307 0.5×	424 0.9×	536 1.5×	584 1.9×	127	3.7k

Countries citing papers authored by Winnie W. Nelson

Since Specialization

Citations

This map shows the geographic impact of Winnie W. Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winnie W. Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winnie W. Nelson more than expected).

Fields of papers citing papers by Winnie W. Nelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Winnie W. Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winnie W. Nelson. The network helps show where Winnie W. Nelson may publish in the future.

Co-authorship network of co-authors of Winnie W. Nelson

This figure shows the co-authorship network connecting the top 25 collaborators of Winnie W. Nelson. A scholar is included among the top collaborators of Winnie W. Nelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Winnie W. Nelson. Winnie W. Nelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Navari, Rudolph M., et al.. (2023). Real-World Treatment Outcomes, Healthcare Resource Use, and Costs Associated with Antiemetics Among Cancer Patients on Cisplatin-Based Chemotherapy. Advances in Therapy. 40(7). 3217–3226. 7 indexed citations

Sharma, Ajay, et al.. (2020). <p>Treatment Patterns and Health Care Costs of Lupus Nephritis in a United States Payer Population</p>. Open Access Rheumatology Research and Reviews. Volume 12. 117–124. 8 indexed citations

Nelson, Winnie W., et al.. (2019). Retrospective Medical Record Review to Describe Use of Repository Corticotropin Injection Among Patients with Uveitis in the United States. Journal of Ocular Pharmacology and Therapeutics. 35(3). 182–188. 16 indexed citations

Rice, J. Bradford, Alan G. White, Lauren M. Scarpati, George J. Wan, & Winnie W. Nelson. (2017). Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review. Clinical Therapeutics. 39(11). 2216–2229. 335 indexed citations breakdown →

Nelson, Winnie W., et al.. (2017). A Retrospective Medical Record Review of Utilization Patterns and Medical Resource Use Associated with Repository Corticotropin Injection among Patients with Rheumatologic Diseases in the United States. Rheumatology and Therapy. 4(2). 465–474. 6 indexed citations

Schein, Jeff, C Michael White, Winnie W. Nelson, et al.. (2016). Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences. Thrombosis Journal. 14(1). 14–14. 50 indexed citations

McHorney, Colleen A., Concetta Crivera, François Laliberté, et al.. (2015). Abstract 13611: Adherence to Non-VKA Oral Anticoagulant Medications Based on the Pharmacy Quality Alliance Measure. Circulation. 132(suppl_3). 1 indexed citations

Laliberté, François, Michel Cloutier, Concetta Crivera, et al.. (2015). Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users. Advances in Therapy. 32(3). 216–227. 25 indexed citations

Lang, Kathleen, Aarti A. Patel, Winnie W. Nelson, et al.. (2014). Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis. BMC Health Services Research. 14(1). 329–329. 25 indexed citations

10.

Patel, Aarti A., et al.. (2014). The Economic Burden to Medicare of Stroke Events in Atrial Fibrillation Populations With and Without Thromboprophylaxis. Population Health Management. 17(3). 159–165. 10 indexed citations

11.

Nelson, Winnie W., et al.. (2014). Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation. Patient Preference and Adherence. 8. 167–167. 28 indexed citations

12.

Suh, Dong‐Churl, et al.. (2013). Factors associated with warfarin discontinuation, including bleeding patterns, in atrial fibrillation patients. Current Medical Research and Opinion. 29(7). 761–771. 15 indexed citations

13.

Laliberté, François, Dominic Pilon, Monika Raut, et al.. (2013). Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation?. Current Medical Research and Opinion. 30(4). 645–653. 26 indexed citations

14.

Nelson, Winnie W., et al.. (2013). Impact of Co-morbidities and Patient Characteristics on International Normalized Ratio Control Over Time in Patients With Nonvalvular Atrial Fibrillation. The American Journal of Cardiology. 112(4). 509–512. 48 indexed citations

15.

Chen, Shih‐Yin, et al.. (2012). Caregiver Assistance Among Medicare Beneficiaries With Atrial Fibrillation and Factors Associated With Anticoagulant Treatment. The American journal of geriatric pharmacotherapy. 10(5). 273–283. 3 indexed citations

16.

LaMori, Joyce, Samir H. Mody, H.J. Gross, et al.. (2012). Dyspepsia and Disease Burden Among Patients With Atrial Fibrillation. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 11(1). 14–19. 10 indexed citations

17.

Piccini, Jonathan P., DaJuanicia N. Holmes, Winnie W. Nelson, et al.. (2011). Abstract 15347: Symptom Status and Treatment Strategy in Contemporary Management of Atrial Fibrillation: Findings From the ORBIT-AF Registry. Circulation. 124.

18.

Schein, Jeff, Rodney W. Hicks, Winnie W. Nelson, Vanja Sikirica, & D. John Doyle. (2009). Patient-Controlled Analgesia-Related Medication Errors in the Postoperative Period. Drug Safety. 32(7). 549–559. 42 indexed citations

19.

Harding, Gale, S. Vallow, Nancy Kline Leidy, et al.. (2007). Ease of care with patient controlled analgesia systems: questionnaire development and validation. Journal of Advanced Nursing. 59(5). 530–541. 24 indexed citations

20.

Raebel, Marsha A., Nikki M. Carroll, Susan E. Andrade, et al.. (2006). Monitoring of drugs with a narrow therapeutic range in ambulatory care.. The Journal of the American Medical Association (JAMA) Network (American Medical Association). 12(5). 268–74. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact